Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland.

Coronary heart disease (CHD) is a complex disorder constituting a major health problem in Western societies. To assess the genetic background of CHD, we performed a genomewide linkage scan in two study samples from the genetically isolated population of Finland. An initial study sample consisted of family material from the northeastern part of Finland, settled by a small number of founders approximately 300 years ago. A second study sample originated from the southwestern region of Finland, settled approximately 2,000 years ago. Families were ascertained through probands exhibiting premature CHD, defined as >50% stenosis of at least two coronary arteries at a young age, as verified by coronary angiography. Both study samples and the pooled data set provided evidence for linkage in two chromosomal regions. A region on chromosome 2q21.1-22 yielded two-point LOD scores of 3.2, 1.9, and 3.7, in the affected sib-pair (ASP) analyses of the northeastern, southwestern, and pooled study samples. The corresponding multipoint maximum-likelihood scores (MLSs) for these three study samples were 2.4, 1.3, and 3.0. In addition, a region on chromosome Xq23-26 resulted in two-point LOD scores of 1.9, 3.5, and 2.9 and in multipoint MLSs of 3.4, 3.1, and 2.5, respectively. In conclusion, this study identifies two loci likely to contribute to premature CHD: one on chromosome 2q21.1-22 and another on chromosome Xq23-26.

[1]  J. Terwilliger Genetic Variation and Human Disease: Principles and Evolutionary Approaches , 1997 .

[2]  M. Nei Molecular Evolutionary Genetics , 1987 .

[3]  V. Salomaa,et al.  Trends in the incidence of and mortality from coronary heart disease in Finland, 1983-1988. , 1992, American journal of epidemiology.

[4]  E. Vartiainen,et al.  Parental history of premature coronary heart disease: an independent risk factor of myocardial infarction. , 1996, Journal of clinical epidemiology.

[5]  H. Tunstall-Pedoe,et al.  Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.

[6]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[7]  J D Terwilliger,et al.  Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set , 1998, Molecular Psychiatry.

[8]  P. Ridker,et al.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.

[9]  D. Weeks,et al.  Comparison of nonparametric statistics for detection of linkage in nuclear families: single-marker evaluation. , 1997, American journal of human genetics.

[10]  A. Keys,et al.  Seven countries. A multivariate analysis of death and coronary heart disease. , 1980 .

[11]  M. Daly,et al.  Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. , 1998, American journal of human genetics.

[12]  K. Weiss,et al.  How many diseases does it take to map a gene with SNPs? , 2000, Nature Genetics.

[13]  M. Laakso,et al.  Diabetes and atherosclerosis: an epidemiologic view. , 1987, Diabetes/metabolism reviews.

[14]  G. Noll,et al.  Pathogenesis of atherosclerosis: a possible relation to infection. , 1998, Atherosclerosis.

[15]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[16]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[17]  J. Manson,et al.  Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. , 1997, Circulation.

[18]  P. Wilson,et al.  Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[19]  S M Grundy,et al.  Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. , 1998, Circulation.

[20]  L. Peltonen,et al.  Linkage disequilibrium in isolated populations: Finland and a young sub-population of Kuusamo , 2000, European Journal of Human Genetics.

[21]  W. Kimberling,et al.  Genetic–Epidemiologic Study of Early–onset Ischemic Heart Disease , 1980, Circulation.

[22]  L Kruglyak,et al.  Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.

[23]  L. Peltonen,et al.  Dual origins of Finns revealed by Y chromosome haplotype variation. , 1998, American journal of human genetics.

[24]  J. Witte,et al.  Genetic dissection of complex traits. , 1994, Nature genetics.

[25]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[26]  H H Göring,et al.  Linkage analysis in the presence of errors III: marker loci and their map as nuisance parameters. , 2000, American journal of human genetics.

[27]  R. Campbell,et al.  Coronary heart disease in high-risk populations: lessons from Finland. , 1990, European heart journal.

[28]  G. Rose Familial Patterns in Ischaemic Heart Disease , 1964, British journal of preventive & social medicine.

[29]  Cécile Fizames,et al.  A comprehensive genetic map of the human genome based on 5,264 microsatellites , 1996, Nature.

[30]  F. Kronenberg,et al.  Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[31]  B. Guldbrandtsen,et al.  POPDIST, version 1.1.1: a program to calculate population genetic distance and identity measures. , 2000, The Journal of heredity.

[32]  W. Kannel,et al.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. , 2020, Annals of internal medicine.

[33]  K H Buetow,et al.  A collection of tri- and tetranucleotide repeat markers used to generate high quality, high resolution human genome-wide linkage maps. , 1995, Human molecular genetics.

[34]  J. Suvisaari,et al.  Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. , 2000, Human molecular genetics.

[35]  L. Kruglyak Prospects for whole-genome linkage disequilibrium mapping of common disease genes , 1999, Nature Genetics.

[36]  J. Terwilliger A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. , 1995, American journal of human genetics.

[37]  E. Vartiainen,et al.  Role of known risk factors in explaining the difference in the risk of coronary heart disease between eastern and southwestern Finland. , 1998, Annals of medicine.

[38]  Leena Peltonen,et al.  A putative vulnerability locus to multiple sclerosis maps to 5p14–p12 in a region syntenic to the murine locus Eae2 , 1996, Nature Genetics.

[39]  H H Göring,et al.  Linkage analysis in the presence of errors IV: joint pseudomarker analysis of linkage and/or linkage disequilibrium on a mixture of pedigrees and singletons when the mode of inheritance cannot be accurately specified. , 2000, American journal of human genetics.

[40]  N. Morton,et al.  Allelic association between marker loci. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Francis S. Collins,et al.  Variations on a Theme: Cataloging Human DNA Sequence Variation , 1997, Science.

[42]  J. Terwilliger,et al.  A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. , 1992, Human heredity.

[43]  Mario Pirastu,et al.  Population choice in mapping genes for complex diseases , 1999, Nature Genetics.

[44]  E. Vartiainen,et al.  Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. , 1999, Circulation.

[45]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[46]  R. Brand,et al.  The relationship of reported parental history to the incidence of coronary heart disease in the Western Collaborative Group Study. , 1970, American journal of epidemiology.

[47]  Brian K. Kobilka,et al.  Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice , 1995, Nature.

[48]  J. Genest,et al.  Clustering of cardiovascular risk factors: targeting high-risk individuals. , 1995, The American journal of cardiology.

[49]  E. Lander,et al.  Complete multipoint sib-pair analysis of qualitative and quantitative traits. , 1995, American journal of human genetics.

[50]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[51]  E. Vartiainen,et al.  Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. , 1994, International journal of epidemiology.

[52]  J R O'Connell,et al.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.

[53]  Cedric A. B. Smith,et al.  COUNTING METHODS IN GENETICAL STATISTICS , 1957 .